The heterogenous nuclear riboprotein S1-1 regulates AT1 receptor gene expression via transcriptional and posttranscriptional mechanisms

  • Arch Biochem Biophys. 2009 Aug 1;488(1):76-82. doi: 10.1016/j.abb.2009.06.002.
Cornelius F H Mueller  1 ,  Anja Berger ,  Sebastian Zimmer ,  Vedat Tiyerili ,  Georg Nickenig
Affiliations
  • 1. Medizinische Klinik und Poliklinik II, Innere Medizin, Universitätsklinikum Bonn, Bonn, Germany. [email protected]
PMID: 19508861 DOI: 10.1016/j.abb.2009.06.002
Abstract

The AT1 Receptor plays an essential role in the pathogenesis of atherosclerosis. AT1 Receptor expression is predominately mediated via mRNA destabilization by mRNA binding proteins. We identified via MALDI-analysis the heterogenous nuclear riboprotein S1-1 as an important regulator of AT1 Receptor mRNA stability. The S1-1 protein possesses multiple nucleolar and cellular functions in vascular smooth muscle cells (VSMC). Overexpression of S1-1 sense resulted in VSMC in significant stabilization of AT1 Receptor mRNA. However, this stabilization of the AT1 Receptor mRNA is accompanied by a significantly reduced AT1 Receptor mRNA transcription as shown via nuclear run-on assay resulting finally in reduced AT1 Receptor mRNA levels. Additionally, S1-1 overexpression leads to increased Apoptosis in VSMC and decreases VSMC proliferation.